Cholesterol, an animal sterol, is a waxy substance found in every cell in our body. Cholesterol is usedas a base for the production of steroid hormones, bile salts, and vitamin D, as well as maintaining cell membrane fluidity. Without cholester- ol we would not be able to properly digest foods, our cell structure would not be able to withstand any changes in temperature, and a significant number of important hormones, such as estrogen and testosterone, could not be produced. Cholesterol is produced in the liver, from the molecule acetyl-coenzyme-A. A key step in the pathway of cholesterol synthesis is the conversion of HMG-CoA into mavalonate, a process that is controlled by the enzyme HMG- CoA reductase (see Figure 1 of the article ‘Red Yeast Rice with Ankascin-568RTM) This enzyme can block the production of cholesterol making it an important target for cholesterol lowering drugs called statins, but it also controls the production of many other molecules such as co-enzyme-Q10.
why there are so many side-effects of taking
these drugs. Nearly 10-12% of patients
on statin drugs will experience statin-induced muscle
pain. Other potential adverse reactions
to statin drugs include elevated liver enzymes,
lung disease, and in a small subset of patients
can even increase risk for type
2 diabetes mellitus.
of cholesterol is synthesized,
recycled, and degraded in the liver. But how does the cholesterol
you eat get to the liver from the
gut? And, how is cholesterol transported from the liver to every cell in the body?
Figure 1 (below) shows the processes underpinning the absorption, transportation, utilisation and excretion of fat and cholesterol in the body. First, cholesterol molecules are transported to the liver via the lymph in complexes called chylomicrons. Chylomicrons are relatively large cholesterol-containing lipid (fat) particles that are processed in the liver, forming ever smaller lipid particles containing a mixture of cholesterol, triglyceride, and protein. These heterogeneous particles are called lipoprotein complexes and are utilized by thebody to ‘chaperone’ cholesterol to where it is needed.
After dietary fat and cholesterol enters the small intestine chylomicrons formed in the intestine are transported, via lymphatics, to the blood vessels of the circulatory system. An enzyme called lipoprotein lipase, present on blood vessel walls, breaks up (hydrolyses) fats (triacyglycerols) contained in chylomicrons, transferring glycerol and fatty acids to tissues to be used as energy. Chylomicron remnants are taken up and processed by the liver, which synthesises vHDL particles and releases them into circulation. Lipoprotein lipase breaks up (hydrolyses) fats (triacyglycerols) contained in vHDL particles (trans- ferring glycerol and fatty acids to tissues to be used as energy). This process forms LDL particles, which are taken up by tissues through a process called endocytosis. Excess LDL particles are taken up by the liver, which also synthesizes and secretes HDL particles into circulation. Circulating HDL particles scavenge excess cholesterol from blood vessels and tissues return excess cholesterol to the liver. In the liver, excess cholesterol is processed into bile acid, which is excreted (eliminated) from the body.
A person may be at risk of developing ‘fatty streaks’ in blood vessels due to the consumption of a high cholesterol diet, with excess cholesterol in LDL particles being deposited in the lining of large and medium-sized blood vessels. Over time, fatty streaks may lead to the formation of atherosclerotic plaques through pathological inflammatory processes, increasing a person’s risk for cardiovascular events. Increasing a person’s HDL cholesterol levels may actually help to scavenge excess cholesterol from blood vessels/ tissues, and return excess cholesterol to the liver for excretion. Strategies for managing cholesterol focus on reducing total cholesterol and LDL cholesterol, while increasing HDL cholesterol levels.
It is useful to think of lipoprotein complexes as cholesterol ‘carriages’ that transport cholesterol around the body via the blood stream. There are several
different types of lipoprotein complex, which are classified based on the ratio of
proteins-to-lipid/ cholesterol that they contain. Low-density lipoprotein (LDL) contains a low proportion of protein
(or a high proportion of lipid/
cholesterol); the main function
of LDL is to transport cholesterol to tissues where it is
utilized for energy. In
contrast, high-density lipoprotein (HDL) contains a high proportion of protein
(or a low proportion of cholesterol); its main function
is to collect excess
cholesterol from tissues and transport it back to the liver for processing and excretion.
Chylomicrons, LDL, and a further class of lipoprotein called very low density lipoproteins (vLDL), all have very high
fat and cholesterol content as compared with protein-rich HDL.
The net effect of this lipoprotein system is that chylomicrons absorbed from the gut, transport
cholesterol to the liver
which synthesizes and secretes
vLDL and LDL particles. vLDL and LDL particles circulating in the blood are
taken up by blood vessels and tissues
which use their lipid/cholesterol content as energy. Excess LDL particles in circulation return to the liver where they are taken up by liver cells via LDL receptors. Liver cells also release HDL
particles into circulation that scavenge excess
cholesterol deposited in blood vessels and tissues. LDL
and HDL cholesterol returning to the liver via
circulation can be stored
or eliminated from the
body (excreted) as bile acid.
High levels of cholesterol, triglycerides, LDL, and trans-fats are linked to increased risk of cardiovascular events such as heart attacks and strokes. The build-up (deposition) of cholesterol in blood vessels and tissues can be due to increased cholesterol synthesis, decreased cholesterol utilisation (for energy), or decreased excretion of cholesterol (as bile acid). The nature of the cause of cholesterol build-up, as well as the form of cholesterol in the plasma (i.e. LDL or HDL), is important when determining disease risk and treatment. Genetic disorders can influence the function of the LDL receptor at the surface (plasma membrane) of liver cells. Reduction in uptake of LDL cholesterol into liver cells via the LDL receptor can result in an increased amount of LDL cholesterol in circulation.
Elevated levels of LDL cholesterol in circulation due to genetic effects can lead to an increased risk of adverse cardiovascular events, irrespective of diet and lifestyle in these patients. However, genetic causes of the increase of cholesterol levels affect only a small proportion of the population diagnosed with high cholesterol; the vast majority of cases of high cholesterol in North America are linked to diet and lifestyle.
Indeed, increased consumption of cholesterol-rich foods can result in increased levels of LDL cholesterol in circulation, which can cause atherosclerosis. Atherosclerosis isdefinedasthe loss of arterial elasticity due to blood vessel stiffening and thickening (narrowing). During atherosclerotic plaque formation, excess LDL cholesterol in circulation is deposited as ‘fatty streaks’ in theinnermostlayer of the lining of large and medium-sized blood vessels. As LDL cholesterol infiltrates into the lining of blood vessels it promotes the production of reactive oxygen species (ROS, highly reactive molecules such as OH, H2O2, and O-) that attract immune cells (white blood cells) called macrophages. Although the precise mechanism is not fully understood, macrophages attracted to the site of the fatty streak become ‘foam cells’ which accumulate in the blood vessel lining.
The formation of an atherosclerotic plaque
results in the recruitment of more and more immune cells, which initiate
an inflammatory process that
contributes to the narrowing of the blood vessel. As the plaque continues to grow it may begin to disrupt blood flow
and even completely block (occlude) the hollow tube (lumen) of the blood
vessel. Narrowing of a blood vessel is called stenosis, and atherosclerotic
plaques weaken blood vessels, which can lead to potentially fatal ruptures.
is an important
set of parameters
to be aware of and are known to increase
a person’s risk
for developing atherosclerosis.
The triad includes 1) high blood LDL levels, 2) low blood HDL levels, and 3)
high blood triglyceride levels. The risk of atherosclerosis is further
increased by the consumption of a low fiber diet – as this reduces the excretion of cholesterol – and an inactive lifestyle
– which may increase the likelihood of the LDL cholesterol
adhering to blood vessels.
Managing Cholesterol with Bergamot Extract
In order to promote healthy cholesterol levels, it is helpful to think of HDL cholesterol as ‘good’ cholesterol and LDL cholesterol as ‘bad’ cholesterol. This is because HDL cholesterol isabletoscavenge excess cholesterol in blood vessels and tissues (transporting it back totheliver for processing/excretion), while LDL cholesterol deposits cholesterol in blood vessels and tissues (contributing to the build-up of fatty streaks and atherosclerotic plaques). Management of cholesterol levels is therefore aimed at increasing the levels of HDL cholesterol – with a diet that is rich in ‘good’ fats, i.e. unsaturated, non-trans- fats, such as those found in olive oil or fish oil – and reducing LDL cholesterol (and total cholesterol) – with a diet that is low in ‘bad’ fats, i.e. saturated and trans-fats.
HDL cholesterol may also be improved by eating the citrus fruit Bergamot (often added to Earl Grey tea), which contains relatively high levels of flavonoids (i.e. neoeriocitrin, neohesperidin, and naringin). A study by Toth et al. (2016) found that supplementation with Bergamot extract reduced total cholesterol levels, LDL cholesterol levels, and triglyceride levels, but increased the level of HDL cholesterol in 80 human patients with moderate hypercholesterolemia (high
blood cholesterol). Other studies
by Glizzoli et al.
(2013, 2014) demonstrated similar findings (reduced total cholesterol levels,
LDL cholesterol levels, and triglyceride levels, but improved HDL cholesterol levels or LDL/ HDL ratio) in a group of 77 human
patients with hypercholesterolemia and 107 human patients with metabolic
syndrome (a risk factor for the
development of cardiovascular disease). Together, these clinical trials support the
use of Bergamont extract as a stand-alone or complimentary therapy (to be taken
in conjunction with cholesterol- lowering statin drugs) that contributes to
In summary, understanding how cholesterol is processed in the body is key to managing healthy cholesterol levels. Natural supplements, such as Bergamot extract, may contribute to reducing total cholesterol and LDL cholesterol, while increasing HDL cholesterol levels and therefore may be useful additions in the management of healthy cholesterol levels.
Total cholesterol The total amount of cholesterol present in a sample of blood (or pasma), regardless of whether a component of chylomicron, vLDL, LDL, or HDL particles. The reduction of total cholesterol, through modification of diet (i.e. low cholesterol diet) is a key strategy for the management of healthy cholesterol levels.
LDL cholesterol Low-density lipoprotein (LDL) cholesterol refers to lipoprotein particles synthesised and secreted into circulation by the liver. This type of lipoprotein particle is low-density because it contains a low ratio of protein-to-lipid.
LDL particles are also called ‘bad’ cholesterol because they are relatively rich in cholesterol, and deposit excess cholesterol in blood vessels and tissues. Reduction of LDL cholesterol is a key strategy for the management of healthy cholesterol levels.
High-density lipoprotein (HDL) has a high protein-to-lipid ratio and is relatively poor in cholesterol. HDL particles actually scavenge excess cholesterol from blood vessels/ tissues. Increasing HDL cholesterol is a key strategy in managing healthy cholesterol levels.
1. Adams SP, et al. Lipid-lowering efficacy of rosuvastatin. Cochrane Database Syst. Rev. 2014;21(11):CD010254. doi: 10.1002/14651858.CD010254.pub2.
2. Babish JG, et al. Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including Citrus bergamia, in subjects with moderate cardiometabolic risk factors. Can. J. Physiol. Pharmacol. 2016;31:1-10.
3. Cappello AR, et al. Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: An Overview. Mini Rev. Med. Chem. 2016;16(8):619-29.
4. Giglio RV, et al. The effect of bergamot on dyslipidemia. Phytomedicine. 2015;30:S0944. doi: 10.1016/j. phymed.2015.12.005.
5. Gliozzi M, et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. Int. J. Cardiol. 2013;170(2):140-5. doi: 10.1016/j.ijcard.2013.08.125. Epub 2013 Sep 8.
6. Gliozzi M, et al. The effect of bergamot-derived polyphenolic fraction on LDL small dense particles and non alcoholic fatty liver disease in patients with metabolic syndrome. Advances in Biological Chemistry. 2014;4(2):129.
7. Mollace V, Sacco I, Janda E, Malara C, Ventrice D, Colica C, Visalli V, Muscoli S, Ragusa S, Muscoli C, Rotiroti D, Romeo F. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: From animal models to human studies. Fitoterapia. 2011;82(3):309-16. doi: 10.1016/j.fitote.2010.10.014.
8. Mora S, et al. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013;128(11):1189-97. doi: 10.1161/CIRCULATIONAHA.113.002671.
9. Toth PP, et al. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Front. Pharmacol. 2016;6:299. doi: 10.3389/fphar.2015.00299.
Many people believe that you can only get fatty liver disease if you abuse alcohol. In fact, another form of liver disease called non-alcoholic fatty liver disease, can develop in people who consume little or no alcohol at all. Non-alcoholic fatty liver disease is an insidious condition that creeps up on you. It can develop in your body over years, showing very few to no symptoms. Non-alcoholic fatty liver disease is commonly associated with people who suffer from obesity. A buildup in fat in the liver, where excess fat is stored, causes this dangerous condition. Left untreated, non-alcoholic fatty liver
THE GOOD, THE BAD, THE UGLY Red yeast rice is a brick-red power food with medicinal properties and a long history. It is made by fermenting cooked white rice with a species of mold from the Monascus family, then drying the product and grinding it into a fine powder. Red yeast rice has been a staple of traditional Chinese medicine and a food source for over a thousand years. In addition to the vibrant color and rich flavor, Monascus adds many beneficial molecules to the rice. One of the most important additions is monacolin K, and it became the first
A new cancer diagnosis can be incredibly stressful. CBS reported on a recent study of 200 cancer patients, which showed that 20 percent of them had PTSD a month after their diagnosis. Even if you don’t have PTSD, you are probably dealing with some very challenging emotional turmoil. How to Manage Your Self-Care Your doctors will primarily focus on medical interventions, so it’s up to you to take care of your mental health. Getting “stuck” in traumatic memories and recurring nightmares are two of the symptoms of PTSD. If you find that anxiety, depression, or other issues are crippling your ability to